• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重期住院患者的体重指数与预后

Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.

作者信息

Lainscak Mitja, von Haehling Stephan, Doehner Wolfram, Sarc Irena, Jeric Tina, Ziherl Kristina, Kosnik Mitja, Anker Stefan D, Suskovic Stanislav

出版信息

J Cachexia Sarcopenia Muscle. 2011 Jun;2(2):81-86. doi: 10.1007/s13539-011-0023-9. Epub 2011 Mar 1.

DOI:10.1007/s13539-011-0023-9
PMID:21766053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3118008/
Abstract

BACKGROUND

Nutritional status, weight loss and cachexia have important prognostic implications in patients with chronic obstructive pulmonary disease (COPD). Body mass index (BMI) has been implicated in COPD risk assessment, but information is mostly limited to composite scores or to patients with stable disease. We aimed to analyse the association between BMI and mortality in acute exacerbation of COPD. METHODS: This retrospective survey included 968 patients hospitalized due to acute exacerbation of COPD at the University Clinic Golnik from February 2002 to June 2007. Vital status was ascertained with Central Population Registry, and database was censored on November 1, 2008. RESULTS: Median BMI was 25.08 kg/m(2) (interquartile range, 21.55-29.05 kg/m(2)) and 210 patients (22%) had BMI < 21 kg/m(2). During median follow-up of 3.26 years (1.79-4.76 years), 430 patients (44%) died. Lowest mortality was found for BMI 25.09-29.05 kg/m(2). When divided per BMI decile, mortality was lowest for BMI 25.09-26.56 kg/m(2) (33%). In univariate analysis, BMI per quartile and BMI per unit increase were predictive for all-cause mortality. In an adjusted model, BMI per 1 kg/m(2) unit increase was associated with 5% less chance of death (hazard ratio 0.95, 95% confidence interval 0.93-0.97). CONCLUSIONS: Low BMI < 21 kg/m(2) is frequent in patients hospitalized due to acute exacerbation of COPD. Higher BMI was independently predictive of better long-term survival. A better outcome in obese patients compared to normal weight is in contrast to primary prevention data but concurs with observations of an obesity paradox in other cardiovascular diseases.

摘要

背景

营养状况、体重减轻和恶病质对慢性阻塞性肺疾病(COPD)患者具有重要的预后意义。体重指数(BMI)已被用于COPD风险评估,但相关信息大多局限于综合评分或病情稳定的患者。我们旨在分析BMI与COPD急性加重期患者死亡率之间的关联。

方法

这项回顾性调查纳入了2002年2月至2007年6月在戈尔尼克大学诊所因COPD急性加重而住院的968例患者。通过中央人口登记处确定生命状态,数据库于2008年11月1日进行审查。

结果

BMI中位数为25.08kg/m²(四分位间距为21.55 - 29.05kg/m²),210例患者(22%)的BMI < 21kg/m²。在中位随访3.26年(1.79 - 4.76年)期间,430例患者(44%)死亡。BMI为25.09 - 29.05kg/m²时死亡率最低。按BMI十分位数划分时,BMI为25.09 - 26.56kg/m²时死亡率最低(33%)。在单因素分析中,BMI每四分位数和BMI每增加一个单位均对全因死亡率具有预测性。在调整模型中,BMI每增加1kg/m²单位与死亡几率降低5%相关(风险比0.95,95%置信区间0.93 - 0.97)。

结论

因COPD急性加重而住院的患者中,BMI < 21kg/m²的情况很常见。较高的BMI是长期生存更好的独立预测因素。与正常体重患者相比,肥胖患者的预后更好,这与一级预防数据相反,但与其他心血管疾病中肥胖悖论的观察结果一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d63/3273753/afb1fc8c0bca/13539_2011_23_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d63/3273753/484215e22581/13539_2011_23_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d63/3273753/afb1fc8c0bca/13539_2011_23_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d63/3273753/484215e22581/13539_2011_23_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d63/3273753/afb1fc8c0bca/13539_2011_23_Fig2_HTML.jpg

相似文献

1
Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期住院患者的体重指数与预后
J Cachexia Sarcopenia Muscle. 2011 Jun;2(2):81-86. doi: 10.1007/s13539-011-0023-9. Epub 2011 Mar 1.
2
A Low Lean-to-Fat Ratio Reduces the Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Patients with a Normal or Low Body Mass Index.低瘦体脂比可降低正常或低体重指数慢性阻塞性肺疾病患者急性加重的风险。
Med Sci Monit. 2019 Jul 14;25:5229-5236. doi: 10.12659/MSM.914783.
3
Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.慢性阻塞性肺疾病急性加重的长期预后:生物标志物、临床变量及急性加重类型的作用
COPD. 2015 Jun;12(3):295-305. doi: 10.3109/15412555.2014.949002. Epub 2014 Sep 17.
4
Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries.慢性阻塞性肺疾病住院患者的长期生存:北欧国家的前瞻性观察研究。
Int J Chron Obstruct Pulmon Dis. 2012;7:571-6. doi: 10.2147/COPD.S34466. Epub 2012 Sep 14.
5
The contribution of estimated dead space fraction to mortality prediction in patients with chronic obstructive pulmonary disease-a new proposal.估算死腔分数对慢性阻塞性肺疾病患者死亡率预测的贡献:新的建议。
PeerJ. 2024 Mar 27;12:e17081. doi: 10.7717/peerj.17081. eCollection 2024.
6
Mid-arm and calf circumferences are stronger mortality predictors than body mass index for patients with chronic obstructive pulmonary disease.对于慢性阻塞性肺疾病患者,上臂和小腿围度比体重指数是更强的死亡预测指标。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 31;11:2075-80. doi: 10.2147/COPD.S107326. eCollection 2016.
7
Obesity and Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.肥胖与慢性阻塞性肺疾病急性加重严重程度的关系。
Ann Am Thorac Soc. 2018 Feb;15(2):184-191. doi: 10.1513/AnnalsATS.201706-485OC.
8
Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease.64例慢性阻塞性肺疾病患者急性加重住院的预测因素。
Am J Respir Crit Care Med. 1999 Jan;159(1):158-64. doi: 10.1164/ajrccm.159.1.9803117.
9
Differences in the Outcome of Patients with COPD according to Body Mass Index.慢性阻塞性肺疾病患者根据体重指数的预后差异。
J Clin Med. 2020 Mar 5;9(3):710. doi: 10.3390/jcm9030710.
10
[Association of BMI with acute exacerbation in mild to moderate chronic obstructive pulmonary disease patients in community: a prospective study].[社区中轻度至中度慢性阻塞性肺疾病患者体重指数与急性加重的关联:一项前瞻性研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Sep 10;43(9):1441-1447. doi: 10.3760/cma.j.cn112338-20211130-00938.

引用本文的文献

1
Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management.慢性阻塞性肺疾病中的肌肉萎缩与血脂异常治疗:对患者管理的影响
Biomedicines. 2025 Jul 24;13(8):1817. doi: 10.3390/biomedicines13081817.
2
Factors influencing the prevalence and death rate of COPD: a pan-database ecological study covering 201 countries and regions from 1990 to 2021.影响慢性阻塞性肺疾病患病率和死亡率的因素:一项涵盖1990年至2021年201个国家和地区的全数据库生态研究。
EClinicalMedicine. 2025 Aug 1;86:103347. doi: 10.1016/j.eclinm.2025.103347. eCollection 2025 Aug.
3
Association of GLP1RAs with risk of chronic obstructive pulmonary disease: evidence from drug target Mendelian randomization.

本文引用的文献

1
Cachexia as a major underestimated and unmet medical need: facts and numbers.恶病质是一种严重被低估且未得到满足的医疗需求:事实与数据。
J Cachexia Sarcopenia Muscle. 2010 Sep;1(1):1-5. doi: 10.1007/s13539-010-0002-6. Epub 2010 Oct 26.
2
Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle.《恶病质、肌肉减少症与肌肉杂志》的作者署名及发表伦理准则
J Cachexia Sarcopenia Muscle. 2010 Sep;1(1):7-8. doi: 10.1007/s13539-010-0003-5. Epub 2010 Oct 26.
3
Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.
胰高血糖素样肽-1受体激动剂与慢性阻塞性肺疾病风险的关联:来自药物靶点孟德尔随机化的证据
Diabetol Metab Syndr. 2025 Jul 28;17(1):295. doi: 10.1186/s13098-025-01866-7.
4
FFMI: A Pivotal Indicator Bridging Pulmonary, Sleep, and Systemic Factors in COPD-OSA Overlap Patients.去脂体重指数:连接慢性阻塞性肺疾病-阻塞性睡眠呼吸暂停重叠患者肺部、睡眠及全身因素的关键指标。
Int J Chron Obstruct Pulmon Dis. 2025 Jun 10;20:1843-1849. doi: 10.2147/COPD.S514400. eCollection 2025.
5
Body Mass Index and Lung Function in Hospitalized Severe AECOPD Patients: Investigating Nonlinear Associations and the Role of Hemoglobin.住院严重慢性阻塞性肺疾病急性加重期患者的体重指数与肺功能:探究非线性关联及血红蛋白的作用
Int J Chron Obstruct Pulmon Dis. 2025 May 1;20:1309-1320. doi: 10.2147/COPD.S521112. eCollection 2025.
6
Association of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) with COPD prevalence and all-cause mortality: a population-based study based on NHANES 2007-2016.非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(NHHR)与慢性阻塞性肺疾病患病率及全因死亡率的关联:一项基于2007 - 2016年美国国家健康与营养检查调查(NHANES)的人群研究。
Front Med (Lausanne). 2025 Apr 3;12:1533744. doi: 10.3389/fmed.2025.1533744. eCollection 2025.
7
Dynamic Risk Status of OSA and Its Association with COPD Incidence and Progression to Oxygen Therapy: Insights from a US National Cohort.阻塞性睡眠呼吸暂停的动态风险状况及其与慢性阻塞性肺疾病发病率和氧疗进展的关联:来自美国全国队列的见解
Int J Chron Obstruct Pulmon Dis. 2025 Mar 21;20:753-766. doi: 10.2147/COPD.S496086. eCollection 2025.
8
The impact of body mass index on mortality in COPD: an updated dose-response meta-analysis.体重指数对 COPD 死亡率的影响:一项更新的剂量-反应荟萃分析。
Eur Respir Rev. 2024 Nov 27;33(174). doi: 10.1183/16000617.0261-2023. Print 2024 Oct.
9
Association of systemic corticosteroid use with prognosis of patients with acute exacerbations of chronic obstructive pulmonary disease in the intensive care unit: a propensity score-matched cohort study.系统皮质类固醇使用与重症监护病房慢性阻塞性肺疾病急性加重患者预后的关系:倾向评分匹配队列研究。
BMC Med. 2024 Oct 23;22(1):488. doi: 10.1186/s12916-024-03705-4.
10
Clinical Characteristics of Overweight Patients With Acute Exacerbation Chronic Obstructive Pulmonary Disease (AECOPD).超重的慢性阻塞性肺疾病急性加重(AECOPD)患者的临床特征。
Clin Respir J. 2024 Aug;18(8):e70001. doi: 10.1111/crj.70001.
恶病质和肌肉减少症中的骨骼肌萎缩:分子病理生理学及运动训练的影响
J Cachexia Sarcopenia Muscle. 2010 Sep;1(1):9-21. doi: 10.1007/s13539-010-0007-1. Epub 2010 Oct 26.
4
Adherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病住院患者对治疗指南的依从性与长期生存。
J Eval Clin Pract. 2011 Aug;17(4):737-43. doi: 10.1111/j.1365-2753.2010.01617.x. Epub 2011 Jan 11.
5
Pulmonary rehabilitation improves exercise capacity and quality of life in underweight patients with chronic obstructive pulmonary disease.肺康复可改善慢性阻塞性肺疾病消瘦患者的运动能力和生活质量。
Respirology. 2011 Feb;16(2):276-83. doi: 10.1111/j.1440-1843.2010.01895.x.
6
Predicting outcomes following hospitalization for acute exacerbations of COPD.预测 COPD 急性加重住院后的结局。
QJM. 2010 Nov;103(11):817-29. doi: 10.1093/qjmed/hcq126. Epub 2010 Jul 26.
7
Self-rated health predicts acute exacerbations and hospitalizations in patients with COPD.自感健康状况可预测 COPD 患者的急性加重和住院情况。
Chest. 2010 Aug;138(2):323-30. doi: 10.1378/chest.09-2459. Epub 2010 Apr 9.
8
Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial.在社区环境中,对患有慢性阻塞性肺疾病且肌肉消瘦的患者进行营养康复的疗效和成本:INTERCOM 试验的预设亚组分析。
J Am Med Dir Assoc. 2010 Mar;11(3):179-87. doi: 10.1016/j.jamda.2009.12.083. Epub 2010 Feb 4.
9
Predictors of outcome after exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病加重后结局的预测因素。
J Gen Intern Med. 2009 Sep;24(9):1043-8. doi: 10.1007/s11606-009-1061-2. Epub 2009 Jul 14.
10
The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.心力衰竭住院患者中慢性阻塞性肺疾病的负担。
Wien Klin Wochenschr. 2009;121(9-10):309-13. doi: 10.1007/s00508-009-1185-8.